Comparing the current results to its competitors, Rosecliff Acquisition I reported Revenue decrease in the 2 quarter 2026 year on year by -30.42 %, despite the revenue increase by the most of its competitors of 64.96 %, recorded in the same quarter.
Rosecliff Acquisition Corp I, despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 180.45 %
Rosecliff Acquisition I's Comment on Competition and Industry Peers
The company operates in a highly competitive industry influenced by new products and technologies. Its DeepView System competes directly with conventional wound care assessment methods and with manufacturers and suppliers of related devices, instruments, and supplies. The market for these products is highly fragmented but is primarily served by a few larger manufacturers and distributors. Competitors identified include Cobalt Product Solutions, Sanmina Corporation, and Plexus Manufacturing, many of which have longer operating histories, greater name recognition, and more resources.
December 12, 2024
Unveiling a Revolutionary Collaboration: Spectral AI Partners with Burn Care Experts for DeepView System Advancements In an era where artificial intelligence continues to redefine technological possibilities, Spectral AI is spearheading a paradigm shift in burn care diagnostics with its innovative DeepView System. The Dallas-based company, known on the NASDAQ as MDAI, has announced a groundbreaking collaboration with national leaders in burn care, marking a significant stride towards revolutionising the field with AI and multi-spectral imaging.The DeepView System, celebrated for its pioneering approach in predicting burn healing potential, received the U.S. FDA s coveted Breakthrough Device Designation in 20...
July 31, 2024
Spectral AI Announces Continuing Progress in Development of Handheld DeepView SnapShot M for Military Field Use: Poster Presentation at 2024 Military Health System Research Symposium Spectral AI, a pioneering medical technology company renowned for its innovative work in the field of artificial intelligence and imaging technology, has recently announced meaningful advancements in the development of its latest product the DeepView SnapShot M. This development was showcased in a poster presentation at the prestigious 2024 Military Health System Research Symposium (MHSRS). The company highlighted the potential for this technology to revolutionize military field trauma care, further underlining its commitment ...
July 24, 2024
Sophisticated article:Spectral AI, a leading artificial intelligence (AI) company focused on medical diagnostics in wound care, has announced a significant expansion of its patent portfolio. With a total of 26 granted patents and 38 pending applications, the company now possesses a formidable collection of intellectual property that bolsters and safeguards its proprietary AI-driven DeepView System wound assessment platform.The recent surge in patents marks a remarkable 30% increase in Spectral AI s patent portfolio. This significant growth underscores the company s commitment to innovation and its dedication to developing cutting-edge technologies that enhance the speed and accuracy of treatment decisions in...
June 27, 2024
In a remarkable achievement, Spectral AI, an artificial intelligence (AI) company specializing in medical diagnostics, has surpassed 90% of the enrollment target for pediatric patients in burn centers for its groundbreaking 2024 pivotal study. This study aims to validate the AI-driven algorithm used by Spectral AI s state-of-the-art DeepView System for burn wound care.Back in January of 2024, Spectral AI had proudly announced the enrollment of their first patient in this pivotal study. The purpose of this research is to validate the efficacy of their proprietary imaging technology, DeepView AI, in assessing burn size and healing, leading to faster and more accurate treatment decisions. It is anticipated that...
June 6, 2024
Spectral AI, an innovative med-tech company, has announced significant progress in its pivotal U.S. Burn Study. The company has enrolled 50% of the target patient population at various burn centers, marking a critical milestone towards the comprehensive analysis of its diagnostic technology. This article summarizes the development and its potential implications for the future of burn care. Burn injuries remain a significant medical challenge, necessitating timely and accurate diagnosis to improve patient outcomes. Spectral AI is addressing this critical need through its advanced diagnostic technology. This article presents the recent progress of Spectral AI in their U.S. pivotal burn study, including curre...
Plexus Corp operates as an electronic manufacturing services (EMS) company. Their business model revolves around providing design, manufacturing, and aftermarket services for various industries including healthcare, aerospace, defense, and technology. They collaborate with their customers to develop and deliver innovative solutions, helping them bring their products to market efficiently and effectively.
Sanmina Corporation's business model revolves around providing integrated manufacturing solutions and services to a diverse range of industries. They specialize in designing, manufacturing, and delivering complex electronic and mechanical products.
Sources:
Rosecliff Acquisition Corp I’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Rosecliff Acquisition Corp I versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
